Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (111-120 of 1,023) with videos related to

Pageof 103
Sort By:
European Heart Journal|October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patientsDouglas S Jacoby, Daniel J Rader
Biochimica Et Biophysica Acta|June 17, 2014
Genetics of lipid traits: Genome-wide approaches yield new biology and clues to causality in coronary artery diseaseSumeet A Khetarpal, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Approach to the patient with extremely low HDL-cholesterolDaniel J Rader, Emil M deGoma
Journal of the American College of Cardiology|July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?Emil M deGoma, Daniel J Rader
Geriatric Nursing (New York, N.Y.)|July 1, 1985
How to decrease wandering, a form of agenda behaviorJ Rader, J Doan, M Schwab
The American Journal of Pathology|May 20, 1998
Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient miceM S Kindy, D J Rader
JAMA|March 7, 1992
Lipoprotein(a). Clinical approach to a unique atherogenic lipoproteinD J Rader, H B Brewer
Clinical Chemistry|March 15, 2013
Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?Stephen R Master, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|June 15, 2013
Cholesterol efflux capacity: full steam ahead or a bump in the road?Amit V Khera, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Does exercise increase HDL cholesterol in those who need it the most?P D Thompson, D J Rader
Pageof 103

Showing results (111-120 of 1,023) with videos related to

Sort By:
Pageof 103
European Heart Journal|October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patientsDouglas S Jacoby, Daniel J Rader
Biochimica Et Biophysica Acta|June 17, 2014
Genetics of lipid traits: Genome-wide approaches yield new biology and clues to causality in coronary artery diseaseSumeet A Khetarpal, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism|October 9, 2012
Approach to the patient with extremely low HDL-cholesterolDaniel J Rader, Emil M deGoma
Journal of the American College of Cardiology|July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?Emil M deGoma, Daniel J Rader
Geriatric Nursing (New York, N.Y.)|July 1, 1985
How to decrease wandering, a form of agenda behaviorJ Rader, J Doan, M Schwab
The American Journal of Pathology|May 20, 1998
Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient miceM S Kindy, D J Rader
JAMA|March 7, 1992
Lipoprotein(a). Clinical approach to a unique atherogenic lipoproteinD J Rader, H B Brewer
Clinical Chemistry|March 15, 2013
Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?Stephen R Master, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|June 15, 2013
Cholesterol efflux capacity: full steam ahead or a bump in the road?Amit V Khera, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Does exercise increase HDL cholesterol in those who need it the most?P D Thompson, D J Rader
Pageof 103